Product Information
PANTOPRAZOLE DR 40 MG SUSP PKT is a generic product labeled by Cipla USA Inc., priced at $4.3944 per EA under NDC 69097053153. Its NADAC has been published 47 times since Aug 6, 2025.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097053153
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA217458On Market Since
4/3/2025
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has been published 47 times since Aug 6, 2025, and over the history we have for it it has declined 32.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3944 per EA |
|---|---|
| All-time high | $6.4752 (Aug 13, 2025) |
| All-time low | $4.0255 (Apr 22, 2026) |
| 52-week high | $6.4752 |
| 52-week low | $4.0255 |
| Median price | $4.3944 |
| Average price | $4.7158 |
| Largest weekly change | -15.4% (Oct 22, 2025) |
| Weeks tracked | 47 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the pantoprazole sodium granules market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE DR 40 MG SUSP PKT?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE DR 40 MG SUSP PKT, manufactured by Cipla USA Inc., is $4.3944 per EA (NDC 69097053153), effective Jun 24, 2026.
How has the price of PANTOPRAZOLE DR 40 MG SUSP PKT changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has declined 32.1%. It has been tracked across 47 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE DR 40 MG SUSP PKT?
Since Aug 6, 2025, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has ranged from a low of $4.0255 (Apr 22, 2026) to a high of $6.4752 (Aug 13, 2025), with a median of $4.3944 per EA.
Are there cheaper alternatives to PANTOPRAZOLE DR 40 MG SUSP PKT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PANTOPRAZOLE DR 40 MG SUSP PKT, so no direct lower-cost alternative is listed.
Who manufactures PANTOPRAZOLE DR 40 MG SUSP PKT?
PANTOPRAZOLE DR 40 MG SUSP PKT (NDC 69097053153) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification